Immunohistochemical Expression of Napsin A, CD82 and Cyclin D1 in Some Renal Tumors
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 71, Issue 7
Abstract
<span>Background: </span><span>most of renal neoplasms are of epithelial origin and they are malignant. Renal cell carcinoma (RCC) accounts for approximately 2% of all cancers. The disease resulted in more than 100,000 yearly deaths worldwide. Histologic diagnosis of renal neoplasms is usually straight forward by routine light microscopy. However, immunohistochemistry may be essential in several contexts, including differentiating renal from non- renal neoplasms, differentiating subtypes of primary renal epithelial neoplasms and diagnosing rare types of renal neoplasms or metastatic RCC in biopsy specimens. </span><span>Aim of the work</span><span>: multiple therapeutic options tailored to an individual patient are now being offered. In view of these developments, availability of a robust and dependable panel of immunohistochemical stains becomes even more important because pathologists are frequently asked to render diagnosis on limited material. </span><span>Material and methods</span><span>: in this study a total number of 50 cases of some types of renal cell tumors were immunohistochemically stained for Napsin A, CD 82 and Cyclin D1. Results: these cases included 18 cases of ccRCC (36%), 16 cases of PRCC (32%), 8 cases of ChRCC (16%) and 8 cases of oncocytoma (16%).</span><span>Conclusion: </span><span>we concluded that napsin A may be useful in differentiating between ccRCC and PRCC (particularly type 1 which showed more vacuolated or clear cytoplasm). CD82 may be useful in differentiating between ChRCC, which was CD82 positive and oncocytoma, which was CD82 negative. Cyclin D1 had no significant value in the differentiation of different types of renal epithelial tumors. </span> <span>Recommendation: </span><span>we recommended the usage of Napsin A in differentiating between ccRCC and PRCC and CD82 in differentiation between ChRCC and oncocytoma. More studies are needed to evaluate napsin A in differentiating between ChRCC and oncocytoma.<br /> </span>
Authors and Affiliations
Eman Helal
Keywords
Related Articles
- EP ID EP584016
- DOI -
- Views 104
- Downloads 0
Evaluation of ALBI, MELD and Child-Pugh Scores as non-Invasive Predictors of Esophageal Varices
Background: the prevalence of esophageal varices (OV) in newly diagnosed cirrhotic patients is approximately 60-80% and the 1-year rate of first variceal bleeding is approximately 5% for small esophageal varices & 15% fo...
Lidocaine for Pain Control during Intrauterine Contraceptive Device Insertion: A Randomized Clinical Trial
<strong>Background: </strong>Intrauterine contraceptive device (IUCD) is one of the most common contraception methods. In a survey of female Fellows of the American College of Obstetricians and Gynecologists, the prevale...
Asthma among Adolescent Secondary-School Girls in Riyadh City, Saudi Arabia
Background: Asthma is one of the most common chronic diseases in children and adults. The prevalence of asthma has increased in developed and developing countries over the last three decades. Our objective was to estima...
Prevalence of Rheumatic Heart Disease and its Risk Factors among Cardiac Patients in Taif City, KSA.
<strong>Background:</strong> exposure of the body’s connective tissue to group A β-hemolytic streptococci, after an infection, causes an inflammatory response called Rheumatic fever (RF). When the heart’s connective tiss...
Plasma Factor VII and Histidine-Rich Glycoprotein as A Potential Markers in Pre Eclampsia
<strong>Background: </strong>Preeclampsia (PE) is a complex and serious multi-system disorder of pregnancy with a worldwide incidence of 5-7% and contributes significantly to maternal and perinatal morbidity and mortalit...